Securities Code: 301015 Securities Abbreviation: Baiyang Pharmaceutical Bond Code: 123194 Bond Abbreviation: Baiyang Convertible Bond Announcement No.: 2026-052 Qingdao Baiyang Pharmaceutical Co., Ltd. Announcement on Expected Triggering of Downward Adjustment Conditions for Baiyang Convertible Bond Conversion Price The Company and all members of the Board of Directors guarantee that the information disclosed is true, accurate, and complete, and that there are no false records, misleading statements, or significant omissions.
Special Reminder:
- Securities Code: 301015 Securities Abbreviation: Baiyang Pharmaceutical
- Bond Code: 123194 Bond Abbreviation: Baiyang Convertible Bond
- Conversion Price: 24.79 RMB/share
- Conversion Period: October 20, 2023 to April 13, 2029
From June 2, 2026 to June 16, 2026, if the closing price of the Company's stock falls below 85% of the current conversion price (i.e., 21.07 RMB/share) for ten trading days within any consecutive thirty trading days, it is expected to trigger the downward adjustment condition for the "Baiyang Convertible Bond" conversion price. Investors are kindly advised to pay attention to investment risks.
I. Basic Information of Convertible Bonds
-
Issuance of Convertible Bonds With the approval of the China Securities Regulatory Commission's "Approval on the Registration of Qingdao Baiyang Pharmaceutical Co., Ltd.'s Issuance of Convertible Corporate Bonds to Unspecified Objects" (Securities Regulatory Permit (2023) No. 613), the Company issued 8,600,000 convertible corporate bonds (hereinafter referred to as "convertible bonds") to unspecified objects. Each bond has a face value of RMB 100, with a total raised capital of RMB 860,000,000. After deducting issuance expenses of RMB 7,788,500, the net raised capital is RMB 852,211,500. Lixin Certified Public Accountants (Special General Partnership) audited the receipt of the aforementioned funds on April 20, 2023, and issued the "Capital Verification Report" (Xin Hui Shi Bao Zi [2023] No. ZG11150). The Company has established a special account for the raised capital as required.
-
Listing of Convertible Bonds The Company's convertible bonds totaling RMB 860 million were listed and traded on the Shenzhen Stock Exchange on May 5, 2023, with the bond abbreviation "Baiyang Convertible Bond" and bond code "123194," as approved by the Shenzhen Stock Exchange.
-
Conversion Period of Convertible Bonds The conversion period for the convertible bonds issued by this offering shall commence on the first trading day six months after the end of the issuance period and end on the maturity date of the convertible bonds, i.e., from October 20, 2023, to April 13, 2029.